Remove 2025 Remove Consulting Remove Provider Remove Screening
article thumbnail

Letitia Bridges, MD, MBA, appointed to chief quality officer at The Permanente Federation

Permanente Medicine

May 22, 2025 — The Permanente Federation has appointed Letitia Bridges, MD, MBA , to the National Permanente Leadership Team as executive vice president and chief quality officer and co-chair of the Kaiser Permanente National Quality Committee. million members.

article thumbnail

Using technology to reclaim our time

Today's Hospitalist

Since the mid-1990s, our capacity for innovation has never stopped as hospitalists navigate a complex landscape of acute illnesses, interprofessional collaborations and the imperative to provide efficient, high-quality care. We have seen explosive growth and become a cornerstone of modern health care systems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Physician Support Groups (Sundays) | Peer Support for Doctors

Pamela Wible MD

View Our 2025 Physician Retreats Confidential support for doctors in crisis. Whether you’re suffering from PHP entrapment, DEA audits, or the stress of building your own business, we provide support, strategies, and connection to help you live your dreams. Connection, healing & hope. You’re not alone.

article thumbnail

Less than Meets the Eye: LDT Small Entity Compliance Guide Adds Little Insight

FDA Law Blog

To be sure, Table 2 provides a handy visual of the categories of LDTs, the timeline for phaseout, and the scope of enforcement discretion for each test category. However, the guidance provides no new information on how FDA expects laboratories to implement these new requirements. 806) and Complaint Files (21 C.F.R.

article thumbnail

Caring for the Unrepresented: A Podcast with Joe Dixon, Timothy Farrell, Yael Zweig

GeriPal

But you worry that the advance directive does not provide enough guidance for the specific decision at Yael Jo, do you. So it defines unrepresented as someone who lacks decisional capacity to provide informed consent to a particular medical treatment. It doesn’t provide enough guidance for the clinicians to make decisions.

article thumbnail

Better Late Than Never – Unpacking FDA’s Highly Anticipated (and Long Overdue) Draft Guidance on Diversity Action Plans

FDA Law Blog

For rare diseases, although patient numbers may be too small to detect meaningful differences in safety or effectiveness, the Draft Guidance states that consistent representative enrollment may still provide opportunities for hypothesis generation and further study. providing language assistance); Reducing participant burden (e.g.,

Clinic 59
article thumbnail

Plenary Abstracts at AAHPM/HPNA: Yael Schenker, Na Ouyang, Marie Bakitas

GeriPal

You did a rural tele-palliative care consultation study. And so the video consult was what became the mode. Marie 03:42 So probably the most important thing is we developed the consultation as a culturally based consultation process. And then we incorporated that information into the consultation process.